Harkness, John H.
Gonzalez, Angela E.
Bushana, Priyanka N.
Jorgensen, Emily T.
Hegarty, Deborah M.
Di Nardo, Ariel A.
Prochiantz, Alain
Wisor, Jonathan P.
Aicher, Sue A.
Brown, Travis E.
Sorg, Barbara A. https://orcid.org/0000-0002-4913-4910
Funding for this research was provided by:
National Institute of General Medical Sciences (GM134789)
National Institute on Drug Abuse (DA033404)
National Institute on Drug Abuse (DA040965)
National Institute of Neurological Disorders and Stroke (NS061800)
Agence Nationale de la Recherche (ANR-18-CE16-0013-01)
Article History
Received: 26 October 2020
Accepted: 21 January 2021
First Online: 14 February 2021
Compliance with ethical standards
:
: JHH and BAS are listed as inventors of the Washington State University analysis program, Pipsqueak™. JHH is a majority stake holder in Rewire Neuro, Inc., the licensing partner of the <i>Pipsqueak</i><sup><i>™</i></sup> technology. The authors do not perceive these relationships to have had an influence on this report.
: All procedures were performed in accordance with the National Institutes of Health's Guidelines for the Care and Use of Laboratory Animals and with approval from the Institutional Animal Care and Use Committee at Legacy Research Institute and Washington State University.